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Figure 1 – MRI demonstrating a large mass inﬁltrating the 
bladder wall.
Figure 2 – Microscopy demonstrating prominent inﬂamma-
tory inﬁltrate rich in histiocytes, with basophilic structures 
with surrounding clear halos (Michaelis-Gutmann bodies, ar-
rows) pathognomonic of malakoplakia (400x, PAS).
A variety of primary tumors originate in the retroperi-
toneum, and they may achieve large volumes before be-
ing diagnosed. The most common retroperitoneal tumors 
are sarcomas, lymphomas, carcinomas, germ cell tumors, 
undifferentiated malignant tumors, and benign tumors1,2. 
Malakoplakia is a chronic granulomatous benign disease 
that is frequently misdiagnosed as a malignant disease3,4. 
We illustrate an unusual case of extensive retroperitoneal 
malakoplakia mimicking retroperitoneal sarcoma.
A 20-year-old male was admitted in our institution 
with a 3-month history of back pain, hematuria, lower uri-
nary tract symptoms, and weight loss of 12 kg. Past medi-
cal history was non-significant. On physical examination, 
he had a scaphoid abdomen with no palpable masses. DRE 
showed a normal prostate, with a large palpable mass with 
undefined limits above the prostate. 
Laboratory tests revealed serum creatinine of 1.5 mg/dL, 
PSA of 0.3 mg/dL, negative HIV-ELISA test, positive urine 
culture for Escherichia coli, negative culture for acid-fast 
bacilli, and a negative PPD.
Ultrasound showed a retrovesical mass with in-
creased blood flow on Doppler. CT scan demonstrated a 
solid heterogeneously enhancing mass topographically 
centered in the left seminal vesicle. The mass measured 
4.5  ×  6.0  ×  5.5  cm, and it infiltrated the prostate gland, 
urinary bladder, and left distal ureter. There was severe 
hydroureteronephrosis with marked reduction of renal 
cortical thickness on the left, and mild right hydroure-
teronephrosis. MRI showed a large retrovesical mass in-
filtrating the bladder (Figure 1). At cystoscopy, the mass 
involved the base and the left wall of the bladder, including 
the left ureteral orifice.
With diagnostic suspicion of retroperitoneal sarcoma, 
TRUS-guided biopsy was performed, which revealed 
chronic sclerotic xanthogranulomatous inflammation. Re-
peated transrectal biopsy showed only acute and chronic 
inflammatory process. Since malignancy was still suspect-
ed, requiring aggressive local resection pending patho-
logical confirmation, the patient underwent transurethral 
resection of the lesion in an attempt to collect more tissue 
for pathologic analysis, and stenting of the right ureter to 
avoid further damage of renal function during investiga-
tion. Histhopathology with periodic acid-Schiff (PAS, 
Figure 2) identified basophilic structures with surround-
ing clear halos (Michaelis-Gutmann bodies), characteris-
tic of malakoplakia.
The patient was treated with fluoroquinolone, 
bethanechol, and vitamin C. Follow-up at 6 and 12 months 
(Figure 3) showed effective and progressive success of clin-
ical therapy, with no need of further surgical intervention.
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DISCUSSION
Malakoplakia is an unusual chronic inflammatory disease 
frequently associated with immunodeficiency and a defec-
tive phagolysosomal activity3-6. It was first described by 
Von Hansemann in 1902, and it is characterized by tumor-
like lesions, single or multiple, which may affect any organ 
of the body3,4,7. It is frequently a diagnostic challenge, in 
which the main differential diagnosis is malignancy5.
Malakoplakia involves the genitourinary tract in 80% 
of cases3,5. The bladder is the most commonly affected or-
gan, followed by the upper urinary tract1,3. Other reported 
locations include the retroperitoneum, gastrointestinal 
tract, central nervous system, female genital tract, lungs, 
adrenal glands, spleen, pancreas, mensenteric nodes, thy-
roid, eyes, skin, and bones3,5,7.
Urinary malakoplakia is more common in females, 
while extraurinary malakoplakia is more frequently seen 
in men4-6. Age of diagnosis ranges from six weeks to 85 
years, peaking in the fifth decade of life5, similar to primary 
sarcoma8. Immunodeficiency disorders and the use of im-
munosuppressive drugs are common9, and most cases are 
associated with urinary tract infection or other systemic 
infections6.
Malakoplakia results from a defective phagocytosis sys-
tem with incomplete bacterial digestion by macrophages 
and histiocytes. Bacterial debris accumulates in the cyto-
plasm of these cells and usually becomes mineralized due 
to deposition of calcium and iron on bacterial glycolipid5-7. 
This basophilic – PAS positive – inclusion structures with 
surrounding clear halos may be visualized by microscopy 
as pathognomonic intracytoplasmic Michaelis-Gutmann 
bodies4,7, which have the appearance of concentric rings9.
Clinically, patients usually present abdominal pain, 
weight loss, diarrhea, hematuria and/or fever, with differ-
ent symptoms according to the affected organ3. Involve-
ment of the bladder is characterized by long-standing 
urinary symptoms and hematuria4. Most cases have posi-
tive urine cultures, usually with Gram-negative bacteria4,9. 
When the ureter is involved, obstruction may lead to loss 
of the ipsilateral renal parenchyma3,4.
Diagnosis of malakoplakia is difficult, and it cannot 
be made exclusively in clinical or imaging ground. De-
finitive diagnosis is based on the hystopathologic findings 
described above3. However, both false-negative and false-
positive diagnosis may occur following biopsy8,9.
Malakoplakia located in the lower urinary tract can 
usually be managed non-surgically. Long-term antibiotics 
such as fluoroquinolones and thrimetoprim-sulfamethox-
azole, both of which achieve high intracellular levels, have 
been shown efficient3,7. There is evidence that concomitant 
use of bethanechol may improve macrophage function6. 
Similarly, ascorbic acid may enhance the effect of bacte-
riolytic enzymes, compromised by associated immune 
deficiency9. Immunosuppressive drugs should be discon-
tinued if possible. In contrast with isolated disease of lower 
urinary tract that usually presents good prognosis, exten-
sive pelvic malakoplakia may be aggressive, invasive, and 
even lethal3,5. Surgical procedures are restricted to unre-
sponsive clinical therapy3. Some cases respond to clinical 
and endoscopic treatment, as in the case reported herein, 
while others may require aggressive surgical intervention6. 
The prognosis of patients with malakoplakia is usually 
good4. Follow-up, however, must be careful because long-
term recurrence may occur3.
Malakoplakia is a chronic benign process that may 
present as a tumoral lesion of the retroperitoneum in-
vading the bladder and adjacent structures. It should al-
ways be kept in mind by surgeons and pathologists as a 
differential diagnosis of retroperitoneal sarcoma to avoid 
iatrogenesis, especially after multiple negative biopsies, in 
which pathognomonic Michaelis-Gutmann bodies should 
be carefully investigated.
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Figure 3 – CT imaging showing reduction of the retroperito-
neal mass (arrow) after 12 months of clinical therapy.
